Further reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver

13 April 2006. Related: Conference reports, Conference index, CROI 13 (Retrovirus) 2006.

Reports from the conference

The reports in the March issue of HTB covered integrase inhibitors, treatment strategies including treatment interruptions, pregnancy, mother-to-child transmission, metabolic complications and primary HIV infection.

Further reports in this issue of HTB include:

• Pharmacokinetics of antiretrovirals in pregnancy: tenofovir, nelfinavir, lopinavir/r

• Risk of central nervous system birth defects associated with ART exposure during pregnancy

• No increase in adverse pregnancy outcomes in Thai women receiving nevirapine-containing HAART

• ARV treatment following singe dose nevirapine exposure

• Association of HIV replication capacity with mother to child transmission

• Association between HIV subtype and detection of K103N

• Pharmacology and drug interaction studies in adults: summary table from CROI, ICAAC and EACS conferences

• Other new antiretrovirals at Denver: the future seems bright

• Origins of HIV traced to chimpanzees in Cameroon

• HSV-2 suppression reduces HIV and HSV shedding

CROI provides some of the best support for people unable to attend the meeting. Abstracts are online already, and are searchable by subject or author. Webcasts of the plenary talks, and this year, for the many oral scientific presentations, are also online, where they can be viewed, including slides, or downloaded as an .mpg audio file.

http://www.retroconference.org

Other websites providing online coverage from the meeting are listed in the On The Web section of HTB.